Rapid Recovery Health Services Announced Today That It Has Named Four Of Its Most Trusted Physician Partners To Its Advisory Board

JERICHO, NY, April 4 /PRNewswire-FirstCall/ -- Rapid Recovery Health Services Ltd...(RPRV: OTCPK) Scott Warantz, CEO announced today that it has appointed a new advisory board. The physicians included in this group are Dr. Marc J. Hudes of New York, Dr. David Geltzer, Dr. Neil Rapport and Dr. James Rubinlicht of Pennsylvania.

Dr. Marc J. Hudes, DPM, DABPS is a graduate of Fairleigh Dickinson University and the New York College of Podiatric Medicine, starting private practice in 1972. He is board certified by the American Board of Podiatric Surgery as well as the American Board of Podiatric Orthopedics and Primary Medicine. He is Chief of Podiatry at the Catskill Regional Medical Center in Harris, NY as well a staff member at Orange Regional Medical Center, Arden Hill Campus & Horton and Ellenville Community Hospital. Dr. Hudes has also served on the faculty of the New York College of Podiatric Medicine as a clinical instructor.

Dr. David Geltzer, DPM, FACFAS is a graduate of the Temple University School of Pharmacy. He received his degree in podiatry from the Pennsylvania College of Podiatric Medicine in 1977 and completed his residency at Broad Street Hospital in Philadelphia. Dr. Geltzer is a member of the American Podiatric Medical Association, is board certified in foot and ankle surgery by the American Board of Podiatric Surgery and is a Fellow of the American College of Foot and Ankle Surgeons. He has also obtained board certification from The American Board of Quality Assurance and Utilization Review Physicians.

Dr. Neil S. Rapport, DPM, FACFAS received his podiatric degree from the Pennsylvania College of Podiatric Medicine in 1975. He completed his residency at Moss Rehabilitation Hospital in 1977. Dr. Rapport is a member of the American Podiatric Medical Association and is board certified in foot and ankle surgery by the American Board of Podiatric Surgery. He is a Fellow of the American College of Foot and Ankle Surgeons and has his board certification from The American Board of Quality Assurance and Utilization Review Physicians.

Dr. Jack Rubinlicht, DPM, FACFAS received his DPM in 1975 from the Pennsylvania College of Podiatric Medicine, now known as Temple University School of Podiatric Medicine. He is board certified by the American Board of Podiatric Surgery, the American Academy of Wound Management, The American Board of Quality Assurance and Utilization Review Physicians and is also a Diplomat of the International College of Laser Surgery. Dr. Rubinlicht is a Fellow of the American College of Foot and Ankle Surgeons and a Member of the American Podiatric Medical Association, the Pennsylvania Podiatric Medical Association, and the Philadelphia Podiatric Medical Society.

About Rapid Recovery

The Company has established a mobile ESWT Program that contracts with over 600 physicians in the NY-NJ-CT Tri-State area and is the exclusive source for low energy ESWT treatment. The mobile program is currently generating in excess of $250,000 in monthly revenue with five systems providing treatment. The Company is interested in establishing mobile routes in the top 100 market areas throughout the United States. Some of the areas include Illinois, Ohio, Wisconsin, Massachusetts, Florida, Maryland, Delaware, Texas, and California. All of which have already established reimbursement schedules for the procedure. The Company already has a fair volume of physician interest in these markets.

Market Size

ESWT is a treatment designed to treat tendonapothies throughout the body that would otherwise require surgical treatment. Based on the demographics of our national population, wide-spread historical statistics on tendon-related ailments and coverage from insurance carriers, the Company conservatively estimates there is a market demand for over 15 million treatments per year. This figure represents approximately 10% of the existing surgical markets of patients with insurance coverage that pays for ESWT. In other words, based on the current mix of insurance payers, with as little as a 10% market penetration into the existing surgical market for patients suffering from tendonapothies, there is a market for 1.25 million procedures per month. The Company sees this figure increasing by 300% - 500% over the next 18 - 36 months as more insurance carriers begin to initiate coverage for ESWT.

Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21B of the Securities and Exchange Act of 1934, as amended. Readers are cautioned not place undue reliance on these forward-looking statements, which are only predictions and only speak as of the date hereof. Forward-looking statements usually contain the words "estimate", "anticipate", "believe", "plan", "expect", or similar expressions and are subject to numerous known and unknown risks and uncertainties. These risks and uncertainties could cause the Company's actual results to differ materially those indicated in the forward-looking statements.

Rapid Recovery Health Services Inc.

CONTACT: about Ortho Shockwave go to http://www.rapidrecoveryinc.com/ or contactthe company at 1(888) 889-0010